Alnylam Pharmaceuticals



Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -105351000 18.32M 2025-03
Alnylam Pharmaceuticals USD 32.48M 123.47M 2025-03
Amgen USD 3.75B 42M 2025-03
Arrowhead Research USD -156177000 1M 2024-12
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Incyte USD 222.66M 97.54M 2025-03
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
Moderna USD -924000000 69M 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 6.82B 1.31B 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Sanofi EUR 563M 3.93B 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Takeda JPY 254.6B 125.66B 2024-12
Tectonic Therapeutic USD -13483000 5.73M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12
Xencor USD 7.14M 64.97M 2024-12



Alnylam Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.